The SUCCESS-C trial: Interim analysis of toxicity evaluating the role of an anthracycline-free chemotherapy regimen in the adjuvant treatment of HER2/neu-negative breast cancer. Cosmetic outcome 1, 2, ...

Interleukin-23 inhibitors, prior treatment history, and Psoriasis Area and Severity Index scores may be predictive of time to disease relapse among patients with psoriasis who achieved clinical ...

Immune Checkpoint Inhibitor Outcomes for Patients With Non–Small-Cell Lung Cancer Receiving Baseline Corticosteroids for Palliative Versus Nonpalliative Indications Median time to relapse was 7.4 ...

Please provide your email address to receive an email when new articles are posted on . Among patients with first-episode psychosis, the effectiveness of antipsychotics for relapse prevention ...

Most DLBCL relapses are symptomatic and occur outside of routine follow-ups, during unscheduled visits often initiated by patients rather than clinicians. Current follow-up strategies show limited ...

IT has long been recognized that many years of observation are needed for proper evaluation of a therapy for pulmonary tuberculosis. Information on the pattern of primary relapse over many years after ...